ATI RN
Virtual ATI Pharmacology Pre Assessment Questions
Question 1 of 5
Common side e昀昀ects of iron supplements include (select all that apply):
Correct Answer: A
Rationale: Iron supplements are known to commonly cause gastrointestinal side effects, such as constipation, upset stomach, and nausea. Constipation is a common side effect of iron supplements due to the way iron can harden the stool and slow down bowel movements. Upset stomach and nausea can occur because iron supplements can irritate the stomach lining, leading to discomfort and feelings of queasiness. It is important for individuals taking iron supplements to be aware of these potential side effects and to speak with their healthcare provider if they are experiencing severe or persistent symptoms.
Question 2 of 5
Two tests should be monitored for a patient currently on Warfarin. What are those two tests? Select ALL that apply.
Correct Answer: A
Rationale: When a patient is on Warfarin therapy, the two primary tests that need to be monitored are the Prothrombin Time (PT) and the International Normalized Ratio (INR). Warfarin works by inhibiting the activity of Vitamin K-dependent clotting factors, and both PT and INR are measures of the extrinsic pathway of coagulation, which is primarily affected by Warfarin. PT measures the time it takes for blood to clot, while INR is a standardized calculation based on the PT value to monitor the effectiveness and safety of Warfarin therapy. Monitoring these tests helps ensure that the patient's blood is not too thick (increased risk of clotting) or too thin (increased risk of bleeding) while on Warfarin.
Question 3 of 5
A patient is to receive a chemotherapy protocol that includes an alkylating agent, an antimetabolite, and an antitumor antibiotic. What is the nurse's best response when the patient asks the nurse why so much chemotherapy is needed?
Correct Answer: B
Rationale: Combination chemotherapy is used to target cancer cells at different stages of the cell cycle and through multiple mechanisms of action. Alkylating agents, antimetabolites, and antitumor antibiotics each work differently: alkylating agents damage DNA, antimetabolites interfere with DNA synthesis, and antitumor antibiotics inhibit RNA synthesis. By combining these drugs, the treatment can kill more cancer cells and reduce the likelihood of resistance. This approach maximizes tumor cell killing while minimizing the risk of relapse. Dose-limiting toxicities still exist, but the combination strategy allows for lower doses of each drug, reducing individual side effects.
Question 4 of 5
Agency that enforces the control of drugs considered to have a potential for abuse:
Correct Answer: B
Rationale: The Drug Enforcement Administration (DEA) is the agency responsible for enforcing the control of drugs considered to have a potential for abuse in the United States. It is the primary federal agency involved in combating drug trafficking and the illegal distribution of controlled substances. The DEA works to regulate and enforce the Controlled Substances Act, which classifies drugs into different schedules based on their accepted medical use and potential for abuse and addiction. This agency plays a crucial role in preventing the diversion and misuse of controlled substances, as well as ensuring public safety and health.
Question 5 of 5
Which of the following is NOT an eicosanoid?
Correct Answer: D
Rationale: Kallidin is a peptide, specifically a kinin, and is not classified as an eicosanoid. Eicosanoids are a group of lipid mediators derived from arachidonic acid or other fatty acids, including prostaglandins, prostacyclin, thromboxane, and leukotrienes. Although kallidin also plays a role in inflammation and vasodilation like some eicosanoids, it is not part of the eicosanoid family.